Director dealing: Somero CEO sells half stake for tax bill
21st Mar 2016 13:19
(ShareCast News) - Somero Enterprises chief executive Jack Cooney and his wife sold off over £2m of the company's shares, reportedly in order to satisfy a US tax bill. The Cooney's sold 1.4m shares, representing 2.49% of the current issued share capital of the company and approximately half of their
Read moreHutchison China first-half profit drops as research spending rises
28th Jul 2015 11:26
(ShareCast News) - Healthcare group Hutchison China MediTech posted a drop in first-half pre-tax profit as it invested more heavily in research and development. For the six months ended 30 June, pre-tax profit came in at $3.9m from $7.3m as a higher spend in R&D and cost of sales offset an increase
Read moreHutchison China Meditech chairman buys £0.8m worth of shares
8th Apr 2015 15:36
Hutchison China MediTech revealed on Wednesday its chairman and secretary bought some shares in the company. Executive director and chairman Simon To on Tuesday purchased 48,000 shares for 1385p each, spending £664,800 in the transaction. Furthermore, non-executive director and secretary Edith Shih
Read moreTo dips in at Hutchinson China-Meditech
20th Nov 2014 15:26
Since falling below 40p in the height of the financial crisis, shares in Hutchison China MediTech (Hutchison Chi-Med) have climbed and climbed and climbed more than 3,000% but executive chairman Simon To seems to believe they can ascend yet higher. To, the founder and managing director of the tradit
Read moreWednesday broker round-up UPDATE
30th Jul 2014 09:50
Antofagasta: Westhouse Securities downgrades from add to neutral with a target price of 885p. Investec places its target price (prev.: 690p) under review, while keeping its sell recommendation. Aureus Mining: FinnCap lowers target price from 66p to 62p maintaining a buy recommendation. British Ame
Read moreMonday broker round-up UPDATE
19th May 2014 07:55
Alent: Numis moves target price from 330p to 340p upgrading to add. AVEVA Group: Westhouse Securities initiates with a target price of 2260p and a buy recommendation. Bovis Homes Group: Deutsche Bank shifts target price from 1039p to 1042p and stays with its buy recommendation. Brown (N) Group: J
Read moreWednesday broker round-up UPDATE
2nd Apr 2014 08:48
Aberdeen Asset Management: Canaccord Genuity reduces target price from 540p to 460p, while its buy recommendation is kept. Anglo American: JP Morgan ups target price from 1260p to 1300p, while leaving its underweight rating unchanged. Aviva: JP Morgan raises target price from 528p to 570p maintain
Read moreFriday broker round-up UPDATE
14th Mar 2014 09:07
Barclays: Nomura reduces target price from 305p to 285p staying with its buy recommendation. Investec lowers target price from 305p to 295p and keeps its buy recommendation. Ferrexpo: Westhouse Securities increases target price from 190p to 220p and reiterates a buy recommendation. F&C Asset Manag
Read moreHutchison China MediPharma director takes stake in company
16th Oct 2013 16:19
Edith Shih, a Non-Executive Director and Company Secretary of Hutchison China MediPharma, acquired 20,000 shares in the firm, which is the holding company of a healthcare group based primarily in China and focused on researching, developing, manufacturing and selling pharmaceuticals and health orien
Read moreHutchison signs Chinese licensing and marketing deal with Eli Lilly
9th Oct 2013 10:58
A business majority owned by Hutchison China MediPharma has entered into a licensing, co-development, and commercialisation agreement in China with US pharmaceutical manufacturer Eli Lilly. The agreement relates to Fruquintinib, an oncology therapy for the potential treatment of various types of s
Read moreWednesday broker round-up UPDATE
9th Oct 2013 07:57
Air Partner: Liberum Capital initiates with a target price of 555p and a buy recommendation. Alent: Credit Suisse moves target price from 420p to 430p and keeps an outperform rating. AZ Electronic Materials: Credit Suisse revises target price from 350p to 330p, while staying with its neutral ratin
Read moreInmarsat Chairman sells 1.4m pounds-worth of shares
8th Aug 2013 15:57
The Chairman of Inmarsat made 1.4m pounds this week by selling around a fifth of his stake in the satellite operator, the firm announced on Thursday. Andrew Sukawaty, who joined the firm 10 years ago, sold 200,000 shares in the company at a price of 700p each, taking advantage of the stock's 20% ri
Read moreThursday broker round-up UPDATE
25th Apr 2013 09:07
Barclays: Morgan Stanley lowers target price from 438p to 424p and reiterates an overweight rating. Bellzone Mining: Investec reduces target price from 21p to 5.28p and downgrades to hold. BG Group: Bank of America cuts target price from 1300p to 1250p retaining a neutral rating. Brown (N) Group:
Read moreHutchison China MediTech to partner with Nestle subsidiary in healthcare JV
12th Apr 2013 12:28
Nestlé Health Science SA, a fully-owned subsidiary of Nestlé SA, and Hutchison China MediTech have announced that all regulatory approvals required for the establishment of a 50/50 joint venture Nutrition Science Partners Limited have been received. Hutchison China MediTech said that the purpose o
Read moreThursday broker round-up UPDATE
29th Nov 2012 07:27
Aberdeen Asset Management: Morgan Stanley raises target price from 365p to 375p; keeping an overweight rating. ASOS: Societe Generale raises target price from 2500p to 2530p and reiterates its hold recommendation. Babcock International: UBS downgrades from buy to neutral. Barratt Developments: HS
Read more